Monkeypox: Changes in Congo strain of monkeypox, many patients do not have symptoms, Indian scientists are studying

Posted on 18th Aug 2022 by rohit kumar

Monkeypox: Scientists in many countries of the world have seen significant changes in the Congolese form of monkeypox infection. Whether there are such changes in the infected patients who have come forward in India so far? A team of the Indian Council of Medical Research (ICMR) based in New Delhi has also started a study regarding this.

 

 

Scientists believe that the study will know the severity of the virus so that it can be prevented. At the same time, there have been many cases in which no symptoms have been shown. Dr. Vinod Scaria, Senior Scientist of IGIB based in New Delhi said, recently a patient from the UK reached America, who was infected with monkeypox. But he had no history of intimate contact, viral prodrome, or wounds.

 

 

He told that such cases have been found in many countries in which there were no symptoms of infection. One such case was also reported in India when a young man died in Kerala. There were no wounds on the skin of the deceased youth.

 

Monkeypox is not fatal in India

 

Former ICMR epidemiologist Dr. Raman Gangakhedkar said, “Monkeypox infection is not fatal for India, as the situation in our country is quite different as of now compared to the US and UK. However, he has also been advised to continue monitoring the infection under epidemiology.

 

31 companies applied to make monkeypox test kits, vaccine

So far 31 companies have received applications for the production of monkeypox virus test kits and vaccines. Of these, eight have shown interest in the vaccine. These include Serum Institute of India in Pune, Reliance Life Sciences, Dr. Reddy\'s Laboratories, Biologicals E, Huffkin Institute in Mumbai, and Indian Immunological Limited Company.

 

India supplies 60% of the vaccines used worldwide: Finance Minister

 

Finance Minister Nirmala Sitharaman said on Wednesday that India accounts for 60 percent of all vaccines used in the world. Releasing the book \'India\'s Vaccine Growth Story\' by Sajjan Singh Yadav, Additional Secretary, Department of Expenditure, the Finance Minister said, India is giving a double dose to every citizen today. The country produced Kovid-19 vaccines even during the lockdown. It was not easy to produce the vaccine on such a large scale and to give the dose to the people.

 

The drug controller\'s term extended by 3 months

 

New Delhi. The tenure of Dr. VG Somani, Drug Controller of India has been extended by three months. On August 14, 2019, the Center appointed Dr. Somani as the Drug Controller.

 

Also Read: Monkeypox public health emergency declared in America: More than 7 thousand cases of infection have been found so far, 1,666 cases in New York alone

Other news